The Procter & Gamble Company (NYSE:PG) Shares Purchased by Schubert & Co

Schubert & Co raised its position in The Procter & Gamble Company (NYSE:PGFree Report) by 3.9% during the third quarter, HoldingsChannel reports. The firm owned 2,819 shares of the company’s stock after buying an additional 105 shares during the quarter. Schubert & Co’s holdings in Procter & Gamble were worth $488,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Legacy Financial Group LLC acquired a new position in shares of Procter & Gamble in the 1st quarter valued at $270,000. Park Avenue Securities LLC grew its holdings in shares of Procter & Gamble by 10.7% during the first quarter. Park Avenue Securities LLC now owns 83,748 shares of the company’s stock worth $13,588,000 after purchasing an additional 8,084 shares during the last quarter. Aprio Wealth Management LLC increased its position in shares of Procter & Gamble by 12.8% during the first quarter. Aprio Wealth Management LLC now owns 6,027 shares of the company’s stock worth $978,000 after purchasing an additional 683 shares in the last quarter. Fragasso Group Inc. lifted its holdings in shares of Procter & Gamble by 1.9% in the 1st quarter. Fragasso Group Inc. now owns 11,143 shares of the company’s stock valued at $1,808,000 after purchasing an additional 210 shares during the last quarter. Finally, Triangle Securities Wealth Management boosted its position in shares of Procter & Gamble by 3.5% in the 1st quarter. Triangle Securities Wealth Management now owns 15,947 shares of the company’s stock valued at $2,587,000 after purchasing an additional 540 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

PG traded up $0.01 on Friday, hitting $171.28. 8,372,536 shares of the company were exchanged, compared to its average volume of 6,692,838. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $177.94. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The firm has a market capitalization of $404.24 billion, a P/E ratio of 28.45, a price-to-earnings-growth ratio of 3.74 and a beta of 0.41. The business’s fifty day moving average is $171.77 and its 200 day moving average is $167.11.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company’s revenue was down .6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.83 EPS. As a group, sell-side analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.35%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 66.94%.

Wall Street Analysts Forecast Growth

PG has been the subject of a number of research reports. Dbs Bank cut Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Deutsche Bank Aktiengesellschaft increased their price target on shares of Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. BNP Paribas began coverage on shares of Procter & Gamble in a research note on Monday, June 24th. They issued an “outperform” rating and a $187.00 price objective on the stock. Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price for the company. in a report on Monday, September 30th. Finally, Citigroup boosted their price target on Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Nine equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $176.21.

Read Our Latest Stock Report on Procter & Gamble

Insider Buying and Selling

In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 96,000 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the completion of the transaction, the chief executive officer now directly owns 13,721 shares in the company, valued at approximately $2,332,570. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 96,000 shares of the firm’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the completion of the transaction, the chief executive officer now owns 13,721 shares of the company’s stock, valued at approximately $2,332,570. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 383,194 shares of company stock worth $65,140,718 in the last three months. Corporate insiders own 0.18% of the company’s stock.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.